Darwish Murad et al developed a prognostic score for evaluating a patient with Budd-Chiari Syndrome. This can help to identify a patient who may benefit from more aggressive management. The authors are from Erasmus Medical Center Rotterdam in The Netherlands.
Patient selection: Budd-Chiari Syndrome
Parameters:
(1) encephalopathy
(2) ascites
(3) prothrombin time relative an INR of 2.3
(4) serum total bilirubin in µmol/L
Parameter |
Finding |
Points |
encephalopathy |
absent |
0 |
|
present |
1.27 |
ascites |
absent |
0 |
|
present |
1.04 |
prothrombin time |
<= 2.3 |
0 |
|
> 2.3 |
0.72 |
score =
= SUM(points for the first three parameters) + (0.004 * (total serum bilirubin))
Interpretation:
• minimum score: near 0
• maximum: near 4
• The higher the score the worse the prognosis.
Score |
Group |
Prognosis |
5-Year Survival |
<= 1.10 |
Class I |
good |
89% |
1.10 to 1.5 |
Class II |
intermediate |
74% |
> 1.5 |
Class III |
poor |
42% |
Specialty: Gastroenterology, Hematology Oncology